Molecular targeting of mitomycin C chemotherapy

International Journal of Cancer

Volumn 72, Issue 4, 1997, Pages 649-656

  Nishiyama, Masahiko ^a   Suzuki, Katsuyuki ^a   Kumazaki, Tsutomu ^a   Yamamoto, Wataru ^a   Toge, Tetsuya ^a   Okamura, Tatsunori ^b   Kurisu, Kaoru ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; DRUG EFFICACY; DRUG TARGETING; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; MYELOID LEUKEMIA; PRIORITY JOURNAL; TARGET CELL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MITOMYCIN; NAD(P)H DEHYDROGENASE (QUINONE); NADPH-FERRIHEMOPROTEIN REDUCTASE; NEOPLASM TRANSPLANTATION; NEOPLASMS; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030787605     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970807)72:4<649::AID-IJC17>3.0.CO;2-6     Document Type: Article

References (20)

1. BELCOURT, M.F., HODNICK, W.F., ROCKWELL, S. and SARTORELLI, A.C., Differential toxicity of mytomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH: cytochrome C (P-450) reductase. Proc. nat. Acad. Sci. (Wash.), 93, 456-460 (1996).
2. COLE, S.P., GHARDWAJ, G., GERLACH, J.H., MACKIE, I.E., GRANT, C.E., ALMQUIST, K.C., STEWART, A.J., KURZ, E.U., DUNCAN, A.M. and DEELEY, R.G., Overexpression of a transporter gene in a multi-resistant human lung cancer cell line. Science, 258, 1650-1654 (1992).
3. CROOKE, S.T. and BRADNER, W.T., Mitomycin C: a review. Cancer Treat. Rev., 3, 121-139 (1976).
4. ERCOLANI, L., FLORENCE, B., DENARO, M. and ALEXANDER, M., Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J. biol. Chem., 263, 15335-15341 (1988).
5. GRIFFITH, O.W., Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem., 106, 207-212 (1980).
6. JAHDE, E., VOLK, T., ATEMA, A., SMETS, L.A., GLUSENLAMP, K.H. and RAJEWSKY, M.F., pH in human tumor xenografts and transplanted rat tumors: effect of insulin, inorganic phosphate, and m-iodobenzylguanidine. Cancer Res., 52, 6209-6215 (1992).
7. JOSEPH, P., XU, Y. and JAISWAL, A.K., Non-enzymatic and enzymatic activation of mitomyein C: identification of a unique cytosolic activity. Int. J. Cancer, 65, 263-271 (1996).
8. KANO, T., SAKAI, M. and MURAMATSU, M., Structure and expression of a human class pi glutathione S-transferase messenger RNA. Cancer Res., 47, 5626-5630 (1987).
9. KENNEDY, K.A., MCGURL, J.D., LEONDARIDIS, L. and ALABASTER, O., pH-dependence of mitomycin C-induced cross-linking activity in EMT6 tumor cells. Cancer Res., 45, 3541-354 (1985).
10. KOHN, K.W., EWING, R.A.G. and ERICKSON, L.C., Measurements of strand breaks and crosslinks by alkaline elution. In: E.C. Freidberg and P.C. Hanawalt (eds.), DNA repair: a laboratory manual of research procedures, pp. 379-401, Dekker, New York (1981).
11. LEE, J.H., NAITO, M. and TSURUO, T., Nonenzymatic reductive activation of 7-N-{{2-{[2-(-L-glutamylamino)ethyl]dithio}ethyl}mitomycin C by thiol molecules: a novel mitomycin C derivative effective on mitomycin C-resistant tumor cells. Cancer Res., 54, 2398-2403 (1994).
12. NISHIYAMA, M., SAEKI, S., AOGI, K., HIRABAYASHI, N. and TOGE, T., Relevance of DT-diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells: differences in in vitro and in vivo systems. Int. J. Cancer, 53, 1013-1016 (1993).
13. POWIS, G., GASDASKA, P.Y., GALLEGOS, A., SHERRIL, K. and GOODMAN, D., Over-expression of DT-diaphorase in transfected NIH3T3 cells does not lead to increased anticancer quinone drug sensitivity: a questionable role for the enzyme as a target for bioreductively activated anticancer drugs. Anticancer Res., 15, 1141-146 (1995).
14. RILEY, R. and WORKMAN, P., DT-diaphorase and cancer chemotherapy. Biochem. Pharmacol., 43, 1657-1669 (1992).
15. RONINSON, I.B., CHIN, J.E., CHOI, K.G., GROS, P., HOUSMAN, D.E., FOJO, A., SHEN, D.W., GOTTESMAN, M.M. and PASTAN, I., Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc. nat. Acad. Sci (Wash.), 83, 4538-4542 (1986).
16. SAEKI, S., NISHIYAMA, M. and TOGE, T., DT-diaphorase as a target enzyme for biochemical modulation of mitomycin C. Hiroshima J. med. Sci., 44, 55-63 (1995).
17. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning. In: A laboratory Manual (2nd ed.), Cold Spring Harbor Laboratory, New York (1989).
18. SHARMA, M. and TOMASZ, M., Conjugation of glutathione and other thiols with bioreductively activated mitomycin C. Effect of thiols on the reductive activation rate. Chem. Res. Toxicol., 7, 390-400 (1994).
19. SINGH, S.V., XU, B.H., MAURYA, A.K. and MIAN, M., Modulation of mitomycin C resistance by slutathione transferase inhibitor ethacrynic acid. Biochem. biophys. Acta, 1137, 257-263 (1992).
20. TRAVER, R.T., HORILOSHI, T., DANENBERG, K.D., STADLBAUER, T.H.W., DANENBERG, P.V., ROSS, D. and GIBSON, N.W., NAD(P)H: quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res., 52, 797-802 (1992).